Skip to content

Study for Shu-Gan Jie-Yu Capsule improved clinical outcomes and decreased hyper-connected brain functional connectivity of mild to moderate depression patients

Study for Shu-Gan Jie-Yu Capsule improved clinical outcomes and decreased hyper-connected brain functional connectivity of mild to moderate depression patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024988
Enrollment
Unknown
Registered
2019-08-06
Start date
2016-06-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Case group:Take Shugan Jieyu Capsule
Control group:no any medication

Sponsors

First Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: According to the International Statistical Classification of Diseases and Related Health Problems (ICD-10) diagnostic criteria for mild to moderate depressive episodes, Hamilton Depression Scale 24 (HAMD-24) 7 < score 24; Han nationality; aged 18 to 50 years male and female; right-handed; clear consciousness, able to complete psychological tests, sign the informed consent.

Exclusion criteria

Exclusion criteria: Those with aphasia, aphasia, visual or auditory impairment, unable to complete psychometric measurements; those with severe organic diseases (severe heart, lung, liver and kidney dysfunction, severe infections, chronic inflammatory diseases, tumors, blood diseases); those who used any psychiatric and neurological drugs within 2 months before admission, or were receiving them within 2 months. Systemic psychotherapy or electroconvulsive therapy; combination of other mental disorders and substance abusers; serious suicide tendency (HAMD-24 suicide project score > 2); with aphasia, aphasia, dementia and other symptoms; not meet the requirements of magnetic resonance scanning (metal materials in vivo, such as pacemaker, metal dentures; claustrophobia).

Design outcomes

Primary

MeasureTime frame
MRI;

Countries

China

Contacts

Public ContactYong Xu

First Hospital of Shanxi Medical University

xuyongsmu@vip.163.com+86 18234016125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 17, 2026